Company Search:
Advanced Search
Sponsored Links
Idt Australia Limited. Company Snapshot
Idt Australia Limited. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Idt Australia Limited. with three other companies in this sector in AUSTRALIA : Immutep Ltd (2020 sales of 13.94 million Australian Dollars [US$10.76 million] of which 99% was Cancer Immunotherapy), Pharmaxis Ltd (12.55 million Australian Dollars [US$9.69 million] of which 56% was Mannitol), and Cellmid Limited (7.48 million Australian Dollars [US$5.78 million] of which 79% was Advangen Japan).

Sales Analysis. Idt Australia Limited. reported sales of A$14.17 million (US$10.94 million) for the fiscal year ending June of 2020. This represents an increase of 16.8% versus 2019, when the company's sales were A$12.13 million. The sales level in 2020 was fairly close to the level five years ago: in 2015, Idt Australia Limited. had sales of A$15.72 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Idt Australia Limited.
  Stock Performance Chart for Idt Australia Limited.
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): .35
(Figures in Australian Dollars)
1 Week -11.5%   13 Weeks 97.1%  
4 Weeks 86.5%   52 Weeks 137.9%  
Idt Australia Limited. Key Data:
  Ticker: IDT Country: Australia
  Exchanges: OTC ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 14,169,000
(Year Ending Jan 2021).
Employees: 156
  Currency: Australian Dollars Market Cap: 82,222,009
  Fiscal Yr Ends: June Shares Outstanding: 238,324,664
  Share Type: Ordinary Closely Held Shares: 75,509,706
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.